Howard Kallender
21Patents
4h-index
30Co-inventors
52Inventor score
Filing activity: Jul 1, 1997 → Oct 26, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5866366A | gidB | Emerging Cross-Sectional Technologies | 100 | Expired |
| US6951729B1 | High throughput screening method for biological agents affecting fatty acid biosynthesis | Physics | 22 | Expired |
| US5910414A | Topoisomerase I of streptococcus pneumoniae | Human Necessities | 5 | Expired |
| US5994101A | DNA encoding gidA1 polypeptides | Human Necessities | 4 | Expired |
| US5866367A | GIDB | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6353093B1 | gidB | Chemistry; Metallurgy | 2 | Expired |
| US6294357A | FabF from Staphylococcus aureus | Human Necessities | 2 | Expired |
| US6168797A | FabF | Human Necessities | 2 | Expired |
| US6331411A | TopA | Human Necessities | 2 | Expired |
| US6238882A | GidA1 | Chemistry; Metallurgy | 1 | Expired |
| US6451556B1 | EF-Tu | Human Necessities | 1 | Expired |
| US6432703B1 | RATC from Streptococcus pneumoniae | Human Necessities | 1 | Expired |
| US6489139B1 | FabZ from Staphylococcus aureus | Human Necessities | 1 | Expired |
| US6210673A | gidB from Staphylococcus aureus | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6403334B1 | gidB from Staphylococcus aureus | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6207449A | gidB from Streptococcus pneumoniae | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6140079A | GidB | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6448038B1 | BirA from staphylococcus aureus | Human Necessities | 0 | Expired |
| US6228364A | GidA1 | Human Necessities | 0 | Expired |
| US6251387A | Topoisomerase I | Human Necessities | 0 | Expired |
| US6214346A | GidB from Streptococcus pneumoniae | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.